In addition, Impaired insulin/insulin-like growth factor-1 (IGF-1) signaling and insulin resistance in MSA patients, as well as increased IGF-1 brain levels in MSA mice have been reported (Ubhi et al. 2010; Numao et al. 2014; Bassil et al. 2017). The gene discussed is IGF1; the disease is multiple system atrophy.